After analyzing the outcomes using Kaplan Meier database, we also revealed that breast cancer patients (n = 1089) with high expression of GOLT1B exhibited poorer OS, DMFS, and RFS (Figure 2B). This evidence concerns the gene GOLT1B and breast carcinoma.